RETALIX LTD.

NOTE 9 – SHAREHOLDERS’ EQUITY (continued):
RETALIX LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
The following table summarizes information about options under the Company’s plans outstanding at December
31, 2005:
Exercise
price
U.S.$
Number of
options
outstanding at
December 31,
2005
F-33
Number of
options
exercisable at
December 31,
2005
Weighted
average
remaining
contractual
life (in
years)
8.75 14,701 4,368 2.33
9.01 80,000 40,000 1.00
10.00 239,316 239,316 2.33
14.88 346,433 346,433 2.33
18.56 909,141 491,049 2.50
21.86 176,556 0 3.00
23.02 239,084 79,695 3.50
23.19 129,767 43,256 2.00
2,134,998 1,244,117
The weighted average exercise price of the total 2,134,998 outstanding options under the Company’s plans as of
December 31, 2005, was $17.63 and the weighted average remaining contractual life of these options as of
December 31, 2005, was 2.5 years.
2) Stock option plan of subsidiaries:
a. On December 4, 2000, a subsidiary’s board of directors approved an employee stock option plan (“the Subsidiary
Plan”). Pursuant to the Subsidiary Plan, 270,000 Ordinary shares, of NIS 0.01 par value, of the subsidiary are
reserved for issuance upon the exercise of 270,000 options to be granted to some of the Company’s and of the
subsidiary’s employees. In addition, within the context of an investment agreement signed on December 31,
2000, an additional 90,000 options to purchase 90,000 shares of NIS 0.01 par value each were granted to the
investor. Virtually all of the above mentioned options except those granted to the investor vest as follows:
33.33% after the first year, another 33.33% after the second year and another 33.33% after the third year, (in
cases where the optionee is an employee of the Company or its subsidiary - provided that the employee is still the
subsidiary’s or the Company’s employee). In addition, all the above options including those granted to the
investor are not exercisable prior to: (1) the consummation of an IPO of the subsidiary’s securities, (2) a merger
of the subsidiary or (3) seven years from the date of grant. The rights conferred by Ordinary shares obtained upon
exercise of the options will be identical to those of the other Ordinary shares of the subsidiary. Any option not
exercised within 10 years of grant date, will expire.